Dementias Completed Phase 2 Trials for Roflumilast (DB01656)

Also known as: Dementia / Dementia NOS / Amentia

IndicationStatusPhase
DBCOND0060453 (Dementias)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01433666Roflumilast and CognitionBasic Science